Data for safe and effective use of evolocumab in paediatric familial hypercholesterolaemia

8 Oct 2020

Kirsty LEE

This content is sponsored. It is intended for healthcare professionals only.

While SARS-CoV2 has been previously reported to exist in lung tissue in a 78-year-old patient who died of unexpected cardiac arrest when ready for discharge after COVID-19 hospitalisation, recently the first evidence of SARS-CoV2 infection in heart muscle cells has been reported in a case from Brazil and which is supported by evidence from other reports.

data-for-safe-and-effective-use-of-evolocumab-in-paediatric-familial-hypercholesterolaemia

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.

Data for safe and effective use of evolocumab in paediatric familial hypercholesterolaemia

Related posts